Aptargroup (ATR) Cash from Financing Activities (2009 - 2026)
Aptargroup (ATR) reported Cash from Financing Activities of -$230.3 million for Q1 2026, down 70.9% year-over-year from -$791.7 million in Q1 2025, and down 400.09% quarter-over-quarter from $76.8 million in Q4 2025.
Aptargroup (ATR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Cash from Financing Activities data on file, last reported at -$230.3 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$230.3 million, down 70.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$173.0 million (up 46.66% YoY), and the FY2025 annual result was -$77.5 million, up 65.62% from the prior year.
- Cash from Financing Activities retreated to -$230.3 million in Q1 2026 per ATR's latest filing, from $76.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $211.9 million in Q1 2022 and troughed at -$230.3 million in Q1 2026.
- A 5-year average of -$51.0 million and a median of -$53.3 million in 2024 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 570.77% in 2022 and fell as far as 32697.49% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$82.0 million in 2022, then gained by 5.42% to -$77.5 million in 2023, then fell by 13.09% to -$87.7 million in 2024, then surged by 187.53% to $76.8 million in 2025, then tumbled by 400.09% to -$230.3 million in 2026.
- Business Quant data shows ATR's Cash from Financing Activities at -$230.3 million in Q1 2026, $76.8 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.34 Mn |
| Mar 31, 2026 | -230.34 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Mar 31, 2024 | -35.75 Mn |
| Mar 31, 2024 | -35.75 Mn |
| Dec 31, 2023 | -77.54 Mn |
| Dec 31, 2023 | -77.54 Mn |